2,10-Dimethyl-phenothiazin | 69520-83-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻嗪类
• 英文名称: 2,10-Dimethyl-phenothiazin
• 英文别名: 3,10-Dimethyl-phenothiazin；2,10-dimethyl-10H-phenothiazine；2,10-dimethyl-phenothiazine；2,10-Dimethylphenothiazine
• CAS: 69520-83-8
• 化学式: C₁₄H₁₃NS
• 分子量: 227.33
• InChiKey: OTOYESNFYXPXIV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  28.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,10-Dimethyl-phenothiazin 、 N,N-二甲基甲酰胺 生成 3-Formyl-2,10-dimethyl-phenothiazin
  参考文献：
  名称：

  Cauquil,G. et al., Bulletin de la Societe Chimique de France, 1964, p. 590 - 597

  摘要：

  DOI：
• 作为产物：
  描述：

  3-甲基二苯胺 在 碘 、 sulfur 作用下， 生成 2,10-Dimethyl-phenothiazin
  参考文献：
  名称：

  Cauquil; Casadevall, Bulletin de la Societe Chimique de France, 1955, p. 768,781

  摘要：

  DOI：

文献信息

• Novel compounds for electronic material and organic electronic device using the same
  申请人：Gracel Display Inc.

  公开号：EP2110376A1

  公开（公告）日：2009-10-21

  The present invention relates to novel compounds for electronic material, and organic electroluminescent devices or organic solar cells comprising the same. Specifically, the compounds for electronic material according to the invention are characterized in that they are represented by Chemical Formula (1): Since the compounds for electronic material, when being applied to an organic electroluminescent device, show good luminous efficiency and excellent life property of material, OLED's having very good operation life can be manufactured therefrom.

  本发明涉及用于电子材料的新型化合物，以及包含它们的有机电致发光器件或有机太阳能电池。具体来说，本发明中的电子材料化合物的特点在于它们由化学式（1）表示： 由于这些电子材料化合物在应用于有机电致发光器件时，表现出良好的发光效率和材料的优异寿命特性，因此可以制造出具有非常良好操作寿命的OLED。
• Compositions useful as inhibitors of voltage-gated sodium channels
  申请人：Gonzalez E. Jesus

  公开号：US20060025415A1

  公开（公告）日：2006-02-02

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
• Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
  申请人：Gonzalez, III Jesus E.

  公开号：US20100087479A1

  公开（公告）日：2010-04-08

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及一种作为电压门控钠离子通道抑制剂有用的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病的方法。
• NITROSATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE
  申请人：EARL Richard A.

  公开号：US20100137291A1

  公开（公告）日：2010-06-03

  The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

  本发明描述了新型亚硝酸化非甾体抗炎药（NSAIDs）及其药学上可接受的盐，以及包含至少一种亚硝酸化NSAID的新型组合物，可选地包含至少一种捐赠、转移或释放一氧化氮、刺激内源性一氧化氮合成、提高内源性内皮衍生松弛因子水平或是一氧化氮合酶底物的化合物，和/或至少一种治疗剂。本发明还提供了包含至少一种亚硝酸化NSAID和至少一种捐赠、转移或释放一氧化氮、提高内源性内皮衍生松弛因子水平、刺激内源性一氧化氮合成或是一氧化氮合酶底物和/或至少一种治疗剂的新型组合物。本发明还提供了包含至少一种亚硝酸化NSAID，可选地包括至少一种一氧化氮供体和/或至少一种治疗剂的新型试剂盒。本发明还提供了治疗炎症、疼痛和发热的方法；治疗胃肠道疾病的方法；促进伤口愈合的方法；治疗和/或预防非甾体抗炎化合物引起的胃肠道、肾脏和/或呼吸道毒性的方法；治疗炎症性疾病状态和/或疾病的方法；以及治疗和/或预防眼科疾病和/或疾病的方法。
• COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS
  申请人：Gonzalez, III Jesus E.

  公开号：US20120238578A1

  公开（公告）日：2012-09-20

  The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包括本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。